|Tumor and microenvironment evolution during immunotherapy with nivolumab|
N Riaz, JJ Havel, V Makarov, A Desrichard, WJ Urba, JS Sims, FS Hodi, ...
Cell 171 (4), 934-949. e16, 2017
|G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma|
Y Wang, J Yang, AT Wild, WH Wu, R Shah, C Danussi, GJ Riggins, ...
Nature communications 10 (1), 943, 2019
|Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy|
RM Samstein, C Krishna, X Ma, X Pei, KW Lee, V Makarov, F Kuo, ...
Nature cancer 1 (12), 1188-1203, 2020
|Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial|
N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ...
JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021
|Detection of early human papillomavirus–associated cancers by liquid biopsy|
RR Damerla, NY Lee, D You, R Soni, R Shah, M Reyngold, N Katabi, ...
JCO precision oncology 3, 1-17, 2019
|Role of Hfq in Genome Evolution: Instability of G-Quadruplex Sequences in E. coli|
VJ Parekh, BA Niccum, R Shah, MA Rivera, MJ Novak, F Geinguenaud, ...
Microorganisms 8 (1), 28, 2019
|Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination|
J Setton, P Selenica, S Mukherjee, R Shah, I Pecorari, B McMillan, IX Pei, ...
NPJ breast cancer 7 (1), 135, 2021
|Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer|
L Chen, T Hollmann, Y Li, N Katabi, R Shah, Y Yu, JJ Kang, CJ Tsai, ...
International Journal of Radiation Oncology, Biology, Physics 106 (5), 1133, 2020
|CADD-27. G-QUADRUPLEX DNA DRIVES GENOMIC INSTABILITY AND REPRESENTS A TARGETABLE MOLECULAR ABNORMALITY IN ATRX-DEFICIENT MALIGNANT GLIOMA|
Y Wang, J Yang, W Wu, R Shah, C Danussi, G Riggins, K Kannan, ...
Neuro-Oncology 20 (Suppl 6), vi280, 2018
|In vitro characterization and clinical correlation of BRCAness as a personalized biomarker for radiosensitization with homologous recombination-directed therapies|
J Ma, AC Bell, J Setton, J Haseltine, M Thompson, R Shah, BH Lok, ...
Cancer Research 77 (13_Supplement), 832-832, 2017